T1	Premise 57 74	45-year-old woman
T2	Premise 76 131	Two previous pregnancies with normal deliveries (G2PN2)
T3	Premise 133 182	Heavy menstrual bleeding for approximately 1 year
T4	Premise 184 263	Ultrasound shows a 2 cm subserosal myoma that has been stable for several years
T5	Premise 265 315	Endometrial biopsy was performed and it was normal
T6	Premise 317 486	The patient has hemoglobin 10 g/dL despite oral ferrotherapy and the amount of menstrual flow has not decreased despite treatment with tranexamic acid and mefenamic acid
T7	Claim 564 604	Total hysterectomy preserving appendages
T8	Claim 609 637	Combined oral contraceptives
T9	Claim 642 662	Endometrial ablation
T10	Claim 667 685	Levonorgestrel IUD
T11	Claim 712 900	According to the SEGO, in perimenopausal women with heavy and/or prolonged menstrual bleeding who require contraception, the levonorgestrel IUD (also called MIRENA IUD) is the first option
R1	Support Ent1:T3 Ent2:T11	
R2	Support Ent1:T11 Ent2:T10	
T12	Treatment 837 855	levonorgestrel IUD
T13	Treatment 869 879	MIRENA IUD
T14	Treatment 564 604	Total hysterectomy preserving appendages
T15	Treatment 609 637	Combined oral contraceptives
T16	Treatment 642 662	Endometrial ablation
T17	Treatment 667 685	Levonorgestrel IUD
